/주식/ALVO
ALVO

ALVO

USD

Alvotech Ordinary Shares

$4.830-0.260 (-5.108%)

실시간 가격

Healthcare
Drug Manufacturers - Specialty & Generic
룩셈부르크

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$5.090

고가

$5.100

저가

$4.700

거래량

0.89M

기업 기본 정보

시가총액

1.5B

산업

Drug Manufacturers - Specialty & Generic

국가

Luxembourg

거래 통계

평균 거래량

0.47M

거래소

NGM

통화

USD

52주 범위

저가 $4.7현재가 $4.830고가 $13.7

관련 뉴스

GlobeNewswire

Alvotech INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (ALVO)

NEW YORK, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Alvotech ("Alvotech" or the "Company") (NASDAQ:ALVO). The investigation concerns whether the

더 보기
Alvotech INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (ALVO)
Analyst Upgrades

Deutsche Bank Downgrades Alvotech to Hold, Lowers Price Target to $8

Deutsche Bank analyst Niall Alexander downgrades Alvotech from Buy to Hold and lowers the price target from $14 to $8.

더 보기
Deutsche Bank Downgrades Alvotech to Hold, Lowers Price Target to $8
GlobeNewswire

Alvotech Provides Update on the Status of U.S. Biologics License Application for AVT05

REYKJAVIK, Iceland, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ:ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today

더 보기
Alvotech Provides Update on the Status of U.S. Biologics License Application for AVT05
GlobeNewswire

Alvotech Announces Changes in Global Business Development and Commercial Operations Team

REYKJAVIK, Iceland, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ:ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced

더 보기
Alvotech Announces Changes in Global Business Development and Commercial Operations Team